Telix partners with EDAP and Profound on prostate imaging tech

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. SPY
2. CRWV
3. SLGN
4. EYPT
5. SLN
6. AIBT
7. LTM:IN
8. PNB:IN
9. EHVVF
10. CHRD

Go back to Telix partners with EDAP and Profound on prostate imaging tech

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

May 15, 2026 6:30 AM EDT

Telix to partner with companies developing advanced minimally invasive and image-guided ablative technologies for prostate cancer.Initial focus on patient selection, treatment planning and post-treatment monitoring; evidence generation to inform best practice.Aim to accelerate adoption of novel therapeutic workflows to enhance clinical decision making and patient outcomes.

MELBOURNE, Australia and INDIANAPOLIS, May 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix) today announces that it has entered into letters of intent to pursue collaborations with EDAP TMS S.A. (NASDAQ: EDAP, EDAP) and Profound Medical Corp. (NASDAQ: PROF, TSX: PRN, Profound),... More